• Olink Webinars

    Getting under the skin of dermatological diseases using protein biomarkers

    An Olink Proteomics-sponsored Science/AAAS  webinar , originally broadcast on 22nd August 2018 , featuring Professors Emma Guttman (Icahn School of Medicine at Mount Sinai New York,) and Professor James G. Krueger (The Rockefeller University New York).  Click the link below to register and access the on-demand recording of these presentations.

    Register here


    Unlocking the elusive mind: The role of protein biomarkers in understanding neurodegenerative disease

    An Olink Proteomics-sponsored Science/AAAS  webinar , originally broadcast on 1st November 2017 , featuring Professors Henrik Zetterberg & Kaj Blennow (Gothenburg University) & Professor Douglas Galasko (University of California, San Diego).  Click the link below to register and access the on-demand recording of these presentations.

    Register here


    Proteogenomic strategies to advance drug development and precision medicine

    An Olink Proteomics-sponsored Science/AAAS  webinar , originally broadcast  on September  6, 2017, featuring Professor Ulf Gyllensten (Uppsala University) and Dr. Anders Mälarstig (Pfizer, Stockholm). Click the link below to register and access the on-demand recording of these presentations.

    Register here


    Introduction to Olink’s Multiplex panels: an innovative tool for protein biomarker research

    This recorded seminar provides an introduction to PEA technology and its applications. Olink’s panels provide a high-throughput multiplex immunoassay product which allows simultaneous detection of 92 protein biomarkers in 90 samples simultaneously using only 1 µL of sample without compromising assay performance.


    Strong impact of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs

    In this recorded webinar, Professor Ulf Gyllensten from Uppsala University presents a large-scale study where 92 protein biomarkers are analyzed in 1,005 healthy individuals from a unique population using an Olink panel focused on oncology. This study reveals that genetics and lifestyle factors are strong influencers of protein levels in the bloodstream and suggests the establishment of personalized cut off values. Personally normalized plasma protein profiles can open up new possibilities of assessing protein biomarkers for prediction, prognosis or targeting different diseases.